10-22209359-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001394757.1(EBLN1):c.625T>A(p.Phe209Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000392 in 1,605,460 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001394757.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000281 AC: 65AN: 231436Hom.: 0 AF XY: 0.000243 AC XY: 31AN XY: 127618
GnomAD4 exome AF: 0.000407 AC: 592AN: 1453230Hom.: 0 Cov.: 33 AF XY: 0.000396 AC XY: 286AN XY: 723132
GnomAD4 genome AF: 0.000243 AC: 37AN: 152230Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2024 | The c.625T>A (p.F209I) alteration is located in exon 1 (coding exon 1) of the EBLN1 gene. This alteration results from a T to A substitution at nucleotide position 625, causing the phenylalanine (F) at amino acid position 209 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at